Do we need MRI in all biopsy naïve patients? A multicenter cohort analysis - Top-Institutions - MDSpire

Do we need MRI in all biopsy naïve patients? A multicenter cohort analysis

  • By

  • Philipp Krausewitz

  • Angelika Borkowetz

  • Gernot Ortner

  • Kira Kornienko

  • Mike Wenzel

  • Niklas Westhoff

  • February 7, 2024

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urology
    • Radiology
    • Oncology

  • #2

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Urology
    • Radiology

  • #3

    Memorial University of Newfoundland - Prostate Cancer Research Group
    Memorial University of Newfoundland - Prostate Cancer Research Group

    St. John's, NL

    Key Differentiators

    • Urology
    • Radiology

  • #4

    University of Heidelberg - Department of Urology
    University of Heidelberg - Department of Urology

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Urology
    • Radiology

  • #5

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Oncology
    • Radiology
    • Urology

Original Source(s)

Do we need MRI in all biopsy naïve patients? A multicenter cohort analysis

  • by Philipp Krausewitz, Angelika Borkowetz, Gernot Ortner, Kira Kornienko, Mike Wenzel, Niklas Westhoff

  • February 7, 2024

Related Content

Development of a nomogram predicting metastatic disease and the assessment of NCCN, AUA and EAU guideline recommendations for bone imaging in prostate cancer patients

T2 mapping for the characterization of prostate lesions

Combining prostate health index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population